Friday, August 27, 2010

ADD / ADHD and Marijuana


What is ADD / ADHD?

Individuals with ADHD essentially have problems with self-regulation and self-motivation, predominantly due to problems with distractibility, procrastination, organization, and prioritization. It is a chronic condition, beginning in early childhood and persisting throughout a person’s lifetime. It is estimated that up to 70% of children with ADHD will continue to have significant ADHD-related symptoms persisting into adulthood, resulting in a significant impact on education, employment, interpersonal relationships, and in social settings.
In layman’s terms, ADHD is a condition in which the brain can not efficiently “ignore” unimporant stimuli. Essentially, a person not suffering from ADHD will have an easier time remaining focused on a specific project and ignore distractions while an ADHD brain is more prone to distraction due to its inability to ignore stimuli.
Current research has shown that certain strains of marijuana can provide focus to people with ADHD and many people have successfully used marijuana as a replacement to other medications (such as Ritalin or Methylphenidate).

Marijuana Facts and Resources:


Thursday, August 26, 2010

1st production Electric HEMP-car to be made in Canada.

'As a structural material,
hemp is about the best.'
Nathan Armstrong, Motive Industries Inc.

An electric car made of hemp is being developed by a group of Canadian companies in collaboration with an Alberta Crown corporation.
The Kestrel will be prototyped and tested later in August by Calgary-based Motive Industries Inc., a vehicle development firm focused on advanced materials and technologies, the company announced.
The compact car, which will hold a driver and up to three passengers, will have a top speed of 90 kilometres per hour and a range of 40 to 160 kilometres before needing to be recharged, depending on the type of battery, the company said in an email to CBC News Monday.
It will be powered by a motor made by Boucherville, Que.-based TM4 Electrodynamic Systems, said Motive Industries president Nathan Armstrong.

Judge makes Anti-Cannabis 'Danger' documentary

Departing Taranaki judge Rob Murfitt is a man on a mission.
He's seen the sad, steady stream of offenders through his courts and the human toll of waste and misery in Taranaki Base Hospital's mental health unit and he has made a connection – cannabis.
Now he is doing something about it before he leaves to take up a new role in Christchurch in October.
The region's Youth Court judge has brought together sponsors, youth workers and Kiwi music stars to produce a film documenting the dangers of the drug.
And his vision will be realised when the 47-minute film premieres next week.
Judge Murfitt used to think cannabis had only mild short-term side effects, "but I don't think that any longer".
He says the drug is "rampant" in Taranaki and that virtually all of the chronic offenders are users.
"With my work in the mental health ward it becomes startlingly obvious to me the connection between heavy cannabis use by young people and the onset of psychotic illness," the judge said.
"So I wanted to create a resource to be able to give to these young people that brings home the message."
Hiding Behind the Green Screen cost about $35,000 to make and was partly funded by offenders themselves, who contributed about $6000 through fines and reparations. Shell also assisted with a substantial sponsorship.
It was produced by Waves psychologist Paora Joseph and features well-known Kiwi musicians Frances Kora, of Kora, and Rio Hemopo, of Trinity Roots and Fat Freddy's Drop. Both have had their own struggle with "weed" and are now clean.
Judge Murfitt praised Mr Joseph for his creative genius and energy which had fuelled the project, which included filming in New Plymouth Prison.
"He created the story line. And as the concept grew so did the cost," he said with a smile.
He was grateful that professional film-makers had given the project hundreds of hours of their time without any guarantee of payment.
Mr Joseph said the documentary would be an invaluable, rare resource and learning tool and a legacy from Judge Murfitt to Taranaki youth.
"There are very few documentaries or resources that allude to marijuana, so it was needed."
Many of the troubled youth who went to Waves were faced with cannabis issues.
Further funding would be needed from the community for the cost of distribution.
The DVD will initially be available free to courts, mental health services, police, schools and CYF within Taranaki.
The film will premier at Govett-Brewster Art Gallery Theatre in New Plymouth on September 4.

Tipped by SmokingJoe
Sunday, August 15, 2010

Katt Williams - WEED Remix...

Saturday, August 14, 2010

Het Gedoogbeleid Soft-Drugs - Achtergrondreportage.

Friday, August 13, 2010

420 Themed '1L$ Coin-Chucker' version. Crowd entertainment tool for second life

This is a Crowd Entertainment Gadget I made for the Virtual gaming universe of SecondLife...

This is 1 of 8 looks / themses available for club, malls and other places who want to entertain real visitors...

Only visible for adult verified accounts.

The NEXT GENERATION in Skill-Camping games...
BOT's don't stand a chance - No more Zombies on your Sim !
Only Real Life Avatars can Participate !

This machine throws 1L$ Coins around your place...
When GroupMemebers Click a 1L$ Coin they get 1L$ payed...
When NON-GroupMemebers Click a 1L$ Coin they get a notification,
that they need to be in the group to be able to collect 1L$ Coins...
(group can be switched on and off)

The Coin-Chucker H.Q. Announcer:
This is extra exposure for ALL Coin-Chucker locations !
and is what will drive more traffic to your place!
All Coin-Chuckers automatically report their settings to The Coin-Chucker H.Q. (link:
The machine starts reporting its settings 15 minutes after any last changes were made thru the options menu.
Avatars who want to find good runnig coin-chucker locations, can go to the Coin-Chucker HQ and wait till they hear/see an Announcement in mainchat looking like this:

[10:26] Announcer:There is a Coin-Chucker shooting 10 Coins Per Hour & Group=Off at secondlife://Putnam/206/86/47/ (Click this link for a landmark !)
[10:42] Announcer: There is a Coin-Chucker shooting 20 Coins Per Hour & Group=On at secondlife://Badly Moor/96/32/66/ (Click this link for a landmark !)
and choose where to go :)

Floating text above Coin-Chucker displays:
- number of coins-per hour
- number of coins Chucked
- number of coins found
- Group On / Off

Easy Setup:
1. RightClick the BoXed - 1L$ Coin-Chucker v3.0 and choose OPEN...
2. Choose Copy contents to Inventory...
3. Find the '1L$ Coin-Chucker' in your inventory and drag it to the ground... (rezz it)
4. Raise the Coin-Chucker at least 6 to 8 meters off the ground (3 large person heights)
5. SET The machine to The group that will be payed when clicking the Coins !!!!
6. Click the Coin-Chucker and Choose Start !
7. u can change the rest of the settings thru the menu (click Coin-Chucker for menu)
Setup Done !

Click the Machine to get options menu.
Start - Starts The Machine.
Stop - Stops The Machine.
GroupOn - Sets machine to pay ONLY to groupmembers of the same group the machine is set to.
GroupOff - Machine Pays to ANNYONE who clicks a coin.
Reset - Resets The Machine and reloads settings.
Help - Gives this Manual Notecard to the Owner
CPH+10 / CPH-10 - Adjust Coins Per Hour by +10 or -10
CPH+100 / CPH-100 - Adjust Coins Per Hour by +100 or -100

Coins Per Hour can ONLY be adjusted while the game is running...
Changing the CPH or the Chuck-Force does not effect the Floating text statistics.
When the Reset Button is used the Statistics are reset to 0.
When you take back the Coin-Chucker to inventory and Re-Rezz it all stats are reset too.

Min. CPH = 10 Coins Per Hour
Max. CPH = 600 Coins Per Hour ( Not Advisable ).
Min. Chuck-Force = 2 - Coins fall almost straight down from the machine..
Max. Chuck-Force = 16 - A very Strong! shot tht can easily cover a full Sim

Note: Coins are TempOnRezz so they do not count for your land-prim-count and will all dissapear automatically.

Some simple owner rules:
The Coin-Chucker MUST be placed in a publically accessible area. Adult land is allowed too as long as its accessible to all adults.
If you choose to run the coin-chucker for Group Only,
It MUST be set to a OPEN TO JOIN for EVERYONE for FREE ! Group !

100% secure & BOT FREE!
- All Coin to Machine and Machine to Coins comunications are base64
password encrypted to prevent Hackers to drain your cash !
- Coins work with random number names wich makes them
undetectable to scanners and such...
- BOT's cant take your Money ;)


Groupname: 1L$ Coin-Chucker
Join this group for updates on New Coin-Chucker Locations
Owners of active Coin-Chuckers announce their place and coins per hour here !

Any Questions please send a NOTECARD to: MrLunk Voom
Instant Messages tend to get lost when I am not online please do send a NoteCard ;)

Instead of Selling this 100% LunkTech Hi Quality Product for 1500L$...
We have chosen to run this on a commission base...
Every time ten people have been Payed (not number of coins shot),one Linden goes to the Creator of This Machine...
Wednesday, August 11, 2010

Bill Hicks Mandatory Marijuana - Stand-up Comedy

Monday, August 9, 2010

Stupid Statements & Great Rebuttals

"Marijuana use is wrong."

  • Whatever one's moral beliefs about marijuana consumption, marijuana laws have caused far more harm than marijuana use itself: marijuana prohibition drained precious criminal justice resources from our communities, made it difficult to keep marijuana from our children, and destroyed the lives and families of otherwise law-abiding citizens.

  • "Marijuana regulation would send the wrong message to teenagers."

  • Regulation would reduce teen access to marijuana by taking it off the streets and regulating it, and sending adults to prison if they sell marijuana to young people. According to the White House, more than half of U.S. teens try marijuana before graduating from high school. In the Netherlands, where marijuana is sold in indoor establishments to adults who are carded for age, teen marijuana use is only 28%.

  • "Marijuana regulation might increase DUI related deaths on the roadways."

  • Driving while intoxicated would still be illegal. And people who want to use marijuana are already using it; there are few adults who would start using marijuana if it were regulated.

  • "Marijuana is a 'gateway' or 'stepping stone' to hard drugs."

  • It's the criminalization of marijuana that's the gateway to hard drugs. When adults enter a liquor store to buy alcohol, they don't find cocaine sitting on the shelf next to bottles of vodka; similarly, if marijuana were regulated, adults who buy marijuana would not be exposed to hard drugs (as they occasionally currently are, via drug dealers). -"Most marijuana users do not go on to use other drugs" U.S. Department of Health and Services, Washington D.C. 1995 pg. 10 -"There is no conclusive evidence that the drug effects of marijuana are causally linked to the subsequent abuse of other illicit drugs." - Report of the Institute of Medicine, 17 March 1999
  • Myth: Marijuana use can lead to an increased risk of schizophrenia later in life.

    The Truth:
     This is a total media scare story.  Different sources of this myth have different numbers.  Some say you are 4.5 times more likely to become schizophrenic if you smoke pot.  This “study” from the UK claims “Smoking just one cannabis joint raises danger of mental illness by 40%”.  Pretty scary isn’t it?  Fortunately these studies are total bullshit.

    There have been many studies promoting the link between cannabis use and the onset of schizophrenia.  It is not the quantity of scientific studies that matters though, it is the quality.  As stated in some of my other marijuana myth posts there are three criteria that need to be satisfied in order to prove causality, these are: Association, Temporal Antecedence and Isolation.  Association means the cause and effect must occur together, temporal antecedence means the effect must follow the cause and isolation means all other causes must be ruled out.  The first two can be shown for pretty much anything.
    For example if I performed a raindance and it rained later in the day I have satisfied association and temporal antecedence but not isolation.  Therefore I cannot scientifically prove that my raindance worked.  If raindances were a controversial topic the media would  then publish the “study” and the headline would read “Recent Study Suggests that Raindance Leads to precipitation”.  Sounds ridiculous right?  Well that is exactly what has been happening with the hundreds of “studies” on cannabis and schizophrenia.
    Isolation has not been proven in the marijuana-schizophrenia link.  In fact evidence to the contrary is indisputable.  Marijuana use has grown significantly in the last 30 years.  If schizophrenia was caused by marijuana use then there should be an observable rise in schizophrenia rates as well.  No such link has been established.  This study from Australia demonstrates these findings (pdf).  Before marijuana became popular less than 1% of the population was diagnosed with schizophrenia, and now that marijuana use in widespread the rate of schizophrenia diagnosis is still less than 1%.
    The Report of the Senate Special Commitee on Illegal Drugs from Canada in 2002 concluded the following,
    No mental pathology directly related to the overuse of cannabis has been reported, which distinguishes this substance from psychostimulants such as MDNA, cocaine or alcohol, heavy and repeated use of which can give rise to characteristic psychotic syndromes. Similarly, cannabis does not seem to precipitate the onset of pre-existing mental dysfunctions (schizophrenia, bipolar depression, etc.).
    Those suffering from schizophrenia are known to use drugs.  In a recent study, 60% of people with schizophrenia were found to use psychotropic drugs and 37% would be diagnosable with a substance use disorder.  It is assumed that people with schizophrenia use drugs to overcome self-esteem issues and negative feelings due to antipsychotic medication and the condition itself.  There are studies that show that cannabis can actually be used to treat the symptoms of schizophrenia (link1link2).  The scientifically accepted factors that contribute to the onset of schizophrenia include genetics and social situations such as childhood abuse, poverty, and racial discrimination.  Social outsiders generally cling to drug use as a means to self-medicate depression or just add a little enjoyment to their lives.
    Three-quarters of persons with schizophrenia develop the disease between 16 and 25 years of age.  The studies that suggest that marijuana causes schizophrenia claim that pot use during adolescence will cause schizophrenia around the age 26.  That is the age that it will occur anyway.  What does marijuana use have to do with it?  Nothing.  Persons who are predisposed to schizophrenia are awkward teenagers and much more likely to use cannabis and other drugs than their peers.  It actually looks like schizophrenia causes some marijuana use!
    Despite lack of evidence the media promotes these studies as true.  Headlines like this, “UK researchers to claim as that pot is causing 14% of schizophrenia cases in the UK” are scary.  These media scare stories are unfounded and designed to create widespread fear around marijuana use, also known as propaganda.  The UK is currently in the middle of a psychological war on cannabis.  Check out some of these recent claims taken from a pot-schizophrenia news story,
    Professor Robin Murray, of the Institute of Psychiatry in London, warned yesterday that the risks were likely to be heightened by the increasing use of powerful skunk cannabis.
    Cannabis has been implicated in a string of vicious killings, including the recent stabbing of fashion designer Lucy Braham.
    These claims are absurd this is pure propaganda.  Unfortunately the majority of people know very little about cannabis and accept these claims as true.
    Monday, August 2, 2010

    Scientific information on Vaporizer use and health.

    Scientific information


    The following citations from scientific journals confirm the benefits of using a vaporizer. We have also added some examples of scientific papers on the use of cannabis for medical purposes. It should be noted however that many of these investigations did not involve a vaporizer but joints, and thus although the researchers may confirm the efficacy of cannabinoids, they often discourage the use of cannabis because of the harmfulness of smoke. Many researchers also list the psychoactivity of cannabis as an undesirable side-effect, but we think this is something patients should decide for themselves.


    Evaluation of a vaporizing device (the Volcano) for the pulmonary administration of tetrahydrocannabinol:
    "What is currently needed for optimal use of medicinal cannabinoids is a feasible, non smoked, rapid-onset delivery system. Cannabis vaporization is a technique aimed at suppressing irritating respiratory toxins by heating cannabis to a temperature where active cannabinoid vapors form, but below the point of combustion where smoke and associated toxins are produced. The goal of this study was to evaluate the performance of the Volcano vaporizer in terms of reproducible delivery of the bioactive cannabinoid tetrahydrocannabinol (THC) by using pure cannabinoid preparations, so that it could be used in a clinical trial. By changing parameters such as temperature setting, type of evaporation sample and balloon volume, the vaporization of THC was systematically improved to its maximum, while preventing the formation of breakdown products of THC, such as cannabinol or delta-8-THC. Inter- and intra-device variability was tested as well as relationship between loaded- and delivered dose. It was found that an average of about 54% of loaded THC was delivered into the balloon of the vaporizer, in a reproducible manner. When the vaporizer was used for clinical administration of inhaled THC, it was found that on average 35% of inhaled THC was directly exhaled again. Our results show that with the Volcano a safe and effective cannabinoid delivery system seems to be available to patients. The final pulmonal uptake of THC is comparable to the smoking of cannabis, while avoiding the respiratory disadvantages of smoking."

    Source: Interscience

    Decreased respiratory symptoms in cannabis users who vaporize:
    "Cannabis smoking can create respiratory problems. Vaporizers heat cannabis to release active cannabinoids, but remain cool enough to avoid the smoke and toxins associated with combustion. Vaporized cannabis should create fewer respiratory symptoms than smoked cannabis. We examined self-reported respiratory symptoms in participants who ranged in cigarette and cannabis use. Data from a large Internet sample revealed that the use of a vaporizer predicted fewer respiratory symptoms even when age, sex, cigarette smoking, and amount of cannabis used were taken into account. Age, sex, cigarettes, and amount of cannabis also had significant effects. The number of cigarettes smoked and amount of cannabis used interacted to create worse respiratory problems. A significant interaction revealed that the impact of a vaporizer was larger as the amount of cannabis used increased. These data suggest that the safety of cannabis can increase with the use of a vaporizer. Regular users of joints, blunts, pipes, and water pipes might decrease respiratory symptoms by switching to a vaporizer."


    Cannabis vs. nicotine smoke:
    "More people are using the cannabis plant as modern basic and clinical science reaffirms and extends its medicinal uses. Concomitantly, concern and opposition to smoked medicine has occurred, in part due to the known carcinogenic consequences of smoking tobacco. Are these reactions justified? While chemically very similar, there are fundamental differences in the pharmacological properties between cannabis and tobacco smoke. Cannabis smoke contains cannabinoids whereas tobacco smoke contains nicotine. Available scientific data, that examines the carcinogenic properties of inhaling smoke and its biological consequences, suggests reasons why tobacco smoke, but not cannabis smoke, may result in lung cancer."

    Medical applications of cannabis:

    "For many years, friends of marijuana argued that it had medical benefits, but the science was slippery -- when the government even permitted the research at all. In 1990, CB(1), the first cannabinoid receptor was discovered. Then endogenous cannabinoids -- body-made chemicals that activated the receptors -- were identified, and everything changed. The second cannabinoid receptor, CB(2), was found in 1993. While CB(2) resides mainly in the immune system, CB(1) is largely a nervous Nellie -- living on nerve cells. Roger Pertwee, a cannabis expert at the University of Aberdeen, says the receptor is "distributed widely throughout the central nervous system and the peripheral nervous system. They are present in their greatest concentration around the hippocampus, cortex, olfactory areas, basal ganglia, cerebellum and spinal cord. This pattern accounts for the effects of cannabinoids on memory, emotion, cognition and movement."

    Source: Whyfiles

    Cannabinoids and pain management:
    "The purpose of this systematic review was to find all of the randomized controlled trials of therapeutic use of cannabis in the management of human pain and then to obtain the best estimates of the efficacy of cannabis compared with either conventional analgesics or placebo. We also sought evidence of adverse effects (safety). [Our conclusion was that] cannabinoids give about the same level of pain relief as codeine in acute postoperative pain."

    Source: PubMed

    Cannabis for AIDS patients (1):
    "Acquired immunodeficiency syndrome (AIDS) is a common cause of death among young adults in the USA. AIDS wasting syndrome is the most common clinical presentation of AIDS. Antiretroviral drug therapy has improved the prognosis of persons with AIDS, but also contributed side effects, particularly nausea and anorexia. Case reports demonstrate persons with AIDS use cannabis as medicine to control nausea, anorexia, and pain, while noting improved mood. Recent clinical research comparing smoked cannabis to oral dronabinol (synthetic THC or Marinol) demonstrates no immune dysfunction in persons using cannabinoids and positive weight gain when cannabinoids are compared to placebo. Harm reduction research indicates that heating cannabis to tempratures well below combustion ("vaporization") yields active cannabinoids and a significant reducation or elimination of toxics (benzene, toluene, napthalene, carbon monoxide, and tars) commonly found in smoked cannabis. More research is indicated but vaporizers appear to substantially reduce what is widely perceived as the leading health risk of cannabis, namely respiratory damage from smoking. In spite of a need for more rigorous scientifically controlled research, an increasing number of persons with AIDS are using cannabis to control nausea, increase appetite, promote weight gain, decrease pain, and improve mood."

    Source: Haworth Press

    Cannabis for AIDS patients (2):
    "In its report, Marijuana and Medicine: Assessing the Science Base, released earlier this year, the Institute of Medicine cited the dangers of smoking as a major drawback. The IOM stated, 'Numerous studies suggest that marijuana smoke is an important risk factor in the development of respiratory disease. Because of the health risks associated with smoking, smoked marijuana should generally not be recommended for long-term medical use.' The IOM suggested that researchers concentrate on isolating medically useful cannabinoids and developing ' rapid-onset, non smoked cannabinoid delivery systems.' Such systems might be similar to the inhalers used for certain asthma medicines."


    Cannabis for cancer patients undergoing chemotherapy:
    "We searched systematically for the strongest evidence of efficacy and harm of cannabis in patients having chemotherapy. We examined whether there is any evidence that cannabis is antiemetic when given concomitantly with emetogenic chemotherapy, how well cannabis works in this setting compared with placebo or conventional antiemetics, the evidence for a dose-response relation, and the profile of adverse effects. [Our research concluded that] cannabinoids were more effective antiemetics than prochlorperazine, metoclopramide, chlorpromazine, thiethylperazine, haloperidol, domperidone, or alizapride. Across all trials, cannabinoids were more effective than active comparators and placebo."

    Source: PubMed

    Cannabinoids in the treatment of glaucoma
    "The leading cause of irreversible blindness is glaucoma, a disease normally characterized by the development of ocular hypertension and consequent damage to the optic nerve at its point of retinal attachment. This results in a narrowing of the visual field, and eventually results in blindness. A number of drugs are available to lower intra ocular pressure (IOP), but, occasionally, they are ineffective or have intolerable side-effects for some patients and can lose efficacy with chronic administration. The smoking of marijuana has decreased IOP in glaucoma patients. Cannabinoid drugs, therefore, are thought to have significant potential for pharmaceutical development."

    Source: ScienceDirect

    Cannabinoids for patients with Multiple Sclerosis:
    "Here we show that cannabinoid (CB) receptor agonism using R(+)-WIN 55,212, delta9-tetrahydrocannabinol, methanandamide and JWH-133 (ref. 8) quantitatively ameliorated both tremor and spasticity in diseased mice. The exacerbation of these signs after antagonism of the CB1 and CB2 receptors, notably the CB1 receptor, using SR141716A and SR144528 (ref. 8) indicate that the endogenous cannabinoid system may be tonically active in the control of tremor and spasticity. This provides a rationale for patients' indications of the therapeutic potential of cannabis in the control of the symptoms of multiple sclerosis, and provides a means of evaluating more selective cannabinoids in the future."

    Source: PubMed

    Emerging Clinical Applications For Cannabis & Cannabinoids, A Review of the Recent Scientific Literature, 2000 - 2008
    "Despite continued political debates regarding the legality of medicinal marijuana, clinical investigations of the therapeutic use of cannabinoids are now more prevalent than at any time in history. A search of the National Library of Medicine's PubMed website quantifies this fact. A keyword search using the terms "cannabinoids, 1996" reveals just 258 scientific journal articles published on the subject for that year. Perform this same search for the year 2007, and one will find over 3,400 published scientific studies.

    While much of the renewed interest in cannabinoid therapeutics is a result of the discovery of the endocannabinoid regulatory system, some of this increased attention is also due to the growing body of testimonials from medicinal cannabis patients and their physicians. Nevertheless, despite this influx of anecdotal reports, much of the modern investigation of medicinal cannabis remains limited to preclinical (animal) studies of individual cannabinoids (e.g. THC or cannabidiol) and/or synthetic cannabinoid agonists (e.g., dronabinol or WIN 55,212-2) rather than clinical trial investigations involving whole plant material.
    As clinical research into the therapeutic value of cannabinoids has proliferated exponentially, so too has investigators' understanding of cannabis' remarkable capability to combat disease. Whereas researchers in the 1970s, 80s, and 90s primarily assessed cannabis' ability to temporarily alleviate various disease symptoms - such as the nausea associated with cancer chemotherapy - scientists today are exploring the potential role of cannabinoids to alter disease progression. Of particular interest, scientists are investigating cannabinoids' capacity to moderate autoimmune disorders such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease, as well as their role in the treatment of neurological disorders such as Alzheimer's disease and amyotrophic lateral sclerosis (a.k.a. Lou Gehrig's disease).
    Investigators are also studying the anti-cancer activities of cannabis, as a growing body of preclinical and clinical data concludes that cannabinoids can reduce the spread of specific cancer cells via apoptosis (programmed cell death) and by the inhibition of angiogenesis (the formation of new blood vessels). Arguably, these latter trends represent far broader and more significant applications for cannabinoid therapeutics than researchers could have imagined some thirty or even twenty years ago."
    This report seeks to provide this guidance by summarizing the most recently published scientific research (2000-2008) on the therapeutic use of cannabis and cannabinoids for 17 separate clinical indications:

    • Alzheimer's disease
    • Amyotrophic lateral sclerosis
    • Diabetes mellitus
    • Dystonia
    • Fibromyalgia
    • Gastrointestinal disorders
    • Gliomas
    • Hepatitis C
    • Human Immunodeficiency Virus
    • Hypertension
    • Incontinence
    • Multiple sclerosis
    • Osteoporosis
    • Pruritis
    • Rheumatoid arthritis
    • Sleep apnea
    • Tourette's syndrome

    In some of these cases, modern science is now affirming longtime anecdotal reports of medicinal cannabis users (e.g., the use of cannabis to alleviate GI disorders). In other cases, this research is highlighting entirely new potential clinical utilities for cannabinoids (e.g., the use of cannabinoids to modify the progression of diabetes).


    Search This Blog

    Find MrLunk on Facebook


    Last 30 days: